MAPT and Alzheimer disease: Notably, miR‐132, identified as downregulated in both AD and T2DM in the present study, stands out for its neuroprotective role by reducing Aβ and tau accumulation and mitigating oxidative stress through the modulation of ERK/MAPK1 signaling (Raffaele et al. 2023).